AMR-001: A Cell Therapy for Acute Myocardial Infarction
Amorcyte’s goal is to develop cell therapies to treat cardiovascular diseases. Our lead product, AMR-001, is an autologous stem cell product for the treatment of damaged heart muscle following acute myocardial infarction.